 |
|
|
|
Ambler class |
Protein name |
PDB code |
Resolution (Å) |
Release date |
UniProt code |
PubMed ID |
DOI |
PDB |
Mutations |
Ligands |
Space group |
Unit cell parameters |
Z value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ▲ ▼ | ||||||||
| B3 | PNGM-1 | 6J4N | 2.10 | 2019-02-27 | 30279316 | 10.1107/S2053230X18012268 | pdb | ZN | P 1 21 1 | 122.274 83.017 163.469 ♦ 90.00 110.55 90.00 | 16 | ||
| B3 | PNGM-1 | 6JKW | 2.29 | 2019-04-17 | 29842976 | 10.1016/J.JGAR.2018.05.021. | pdb | MSE ZN | P 1 21 1 | 121.857 83.124 162.833 ♦ 90.00 110.18 90.00 | 16 | ||
| B3 | PNGM-1 | 7BYQ | 1.96 | 2021-04-28 | A0A2U8UYM6 | 32664695 | 10.3390/IJMS21144926 | pdb | ZN | P 1 21 1 | 121.380 83.057 163.581 ♦ 90.00 110.69 90.00 | 8 | |
| B3 | PNGM-1 | 7BZ1 | 2.45 | 2021-04-28 | A0A2U8UYM6 | 32664695 | 10.3390/IJMS21144926 | pdb | ZN | C 1 2 1 | 121.638 82.545 163.716 ♦ 90.00 110.77 90.00 | 16 | |
| B3 | PNGM-1 | 7BZ3 | 2.00 | 2021-04-28 | A0A2U8UYM6 | 32664695 | 10.3390/IJMS21144926 | pdb | ZN | P 1 21 1 | 79.787 143.741 79.760 ♦ 90.00 111.82 90.00 | 8 | |
| B3 | PNGM-1 | 7BZ4 | 2.16 | 2021-04-28 | A0A2U8UYM6 | 32664695 | 10.3390/IJMS21144926 | pdb | ZN | C 1 2 1 | 121.857 82.964 164.037 ♦ 90.00 110.94 90.00 | 16 | |
| B3 | PNGM-1 | 7BZI | 1.94 | 2021-04-28 | A0A2U8UYM6 | 32664695 | 10.3390/IJMS21144926 | pdb | ZN | P 1 21 1 | 121.380 83.057 163.581 ♦ 90.00 110.69 90.00 | 16 | |
| B3 | PNGM-1 | 7WI1 | 1.61 | 2023-01-18 | A0A2U8UYM6 | pdb | ZN | P 1 21 1 | 121.755 82.792 164.047 ♦ 90.00 111.10 90.00 | 16 |
Statistics (number of structures): Overall (1663); class A (626); subclass B1 (403); subclass B2 (16); subclass B3 (104); class C (246); class D (268).
Last updated: November 20, 2024.
If you use BLDB please cite: Naas, T.; Oueslati, S.; Bonnin, R. A.; Dabos, M. L.; Zavala, A.; Dortet, L.; Retailleau, P.; Iorga, B. I., Beta-Lactamase DataBase (BLDB) – Structure and Function. J. Enzyme Inhib. Med. Chem. 2017, 32, 917-919.
The development of the BLDB database was funded in part by the JPIAMR transnational project DesInMBL, the Région Ile-de-France (DIM Malinf) and the Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT).
Contact: contact@bldb.eu